Prognostic value and clinicopathological significance of proliferating cell nuclear antigen expression in gastric cancer: a systematic review and meta-analysis

Songcheng Yin(Sun Yat-sen University), Huimian Xu(First Hospital of China Medical University), Zhan Li(State Key Laboratory of Respiratory Disease), Zhi‐Feng Miao(Kaohsiung Medical University), Junyan Zhang(China Medical University), Chunyang Lu(Peking University), Hao Xu(Wenzhou Medical University), Jinyu Huang(Soochow University)

OncoTargets and Therapy

January 1, 2017

10.2147/ott.s126551

Cited by 19

Related Papers

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021

|Cancer Communications|2021|657

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial

|The Lancet Oncology|2021|436

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023

|癌症：英文版|2023|412

Non-coding RNAs participate in the regulatory network of CLDN4 via ceRNA mediated miRNA evasion

|Nature Communications|2017|268

Regenerative proliferation of differentiated cells by mTORC1‐dependent paligenosis

|The EMBO Journal|2018|207